Curcumin suppresses migration and proliferation of Hep3B hepatocarcinoma cells through inhibition of the Wnt signaling pathway

被引:90
作者
Kim, Hyun Jung [1 ]
Park, Song Yi [1 ]
Park, Ock Jin [2 ]
Kim, Young-Min [1 ]
机构
[1] Hannam Univ, Dept Biol Sci & Biotechnol, Taejon 305811, South Korea
[2] Hannam Univ, Dept Food & Nutr, Taejon 305811, South Korea
基金
新加坡国家研究基金会;
关键词
curcumin; apoptosis; migration; Wnt signaling pathway; hepatocarcinoma; BETA-CATENIN; TUMOR-GROWTH; APOPTOSIS; CANCER; CHEMOPREVENTION; ACTIVATION; AKT; KINASE; TARGET;
D O I
10.3892/mmr.2013.1497
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Curcumin, the major phytochemical in turmeric, exerts anti-proliferative, anticancer and anti-inflammatory activities in various types of cancer cells. Curcumin has been demonstrated to induce apoptosis through multiple signaling pathways; however, its association with survival pathways, including the Wnt signaling pathway, is not fully understood. The Wnt signaling pathway is involved in diverse functions, including cell development, growth and proliferation. This pathway is important for cancer cell survival and metastasis. beta-catenin and GSK3 beta play a key role in the Wnt signaling pathway and therefore, various members of the Wnt signaling pathway have been hypothesized to represent potential targets for anticancer therapy. In the present study, the effect of curcumin on the suppression of migration and proliferation of Hep3B hepatocarcinoma cells was investigated via suppression of Wnt signaling in vitro and in vivo. 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cell migration was observed to be suppressed by curcumin treatment. In addition, curcumin suppressed TPA-induced activation of Wnt signaling. These results indicate that curcumin induces anti-migratory activity, which functions via the Wnt signaling pathway.
引用
收藏
页码:282 / 286
页数:5
相关论文
共 25 条
[1]
[Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107
[2]
Wnt signaling: a common theme in animal development [J].
Cadigan, KM ;
Nusse, R .
GENES & DEVELOPMENT, 1997, 11 (24) :3286-3305
[3]
Wnt signaling to β-catenin involves two interactive components -: Glycogen synthase kinase-3β inhibition and activation of protein kinase C [J].
Chen, RH ;
Ding, WV ;
McCormick, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) :17894-17899
[4]
Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-κBp65 expression in breast cancer MDA-MB-231 cells [J].
Chiu, Tsung-Lang ;
Su, Chin-Cheng .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (04) :469-475
[5]
GSK-3β inhibition -: At the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma [J].
Dal Col, Jessica ;
Dolcetti, Riccardo .
CELL CYCLE, 2008, 7 (18) :2813-2816
[6]
Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model [J].
Dujic, Jadranka ;
Kippenberger, Stefan ;
Ramirez-Bosca, Ana ;
Diaz-Alperi, Joaquin ;
Bereiter-Hahn, Juergen ;
Kaufmann, Roland ;
Bernd, August ;
Hofmann, Matthias .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) :1422-1428
[7]
Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of β-catenin and TCF/LEF-mediated transcriptional activation [J].
Esufali, S ;
Bapat, B .
ONCOGENE, 2004, 23 (50) :8260-8271
[8]
Dickkopfs and Wnt/beta-catenin signalling in liver cancer [J].
Fatima, Sarwat ;
Lee, Nikki P. ;
Luk, John M. .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (08) :311-325
[9]
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth [J].
Inoki, Ken ;
Ouyang, Hongjiao ;
Zhu, Tianqing ;
Lindvall, Charlotta ;
Wang, Yian ;
Zhang, Xiaojie ;
Yang, Qian ;
Bennett, Christina ;
Harada, Yuko ;
Stankunas, Kryn ;
Wang, Cun-yu ;
He, Xi ;
MacDougald, Ormond A. ;
You, Ming ;
Williams, Bart O. ;
Guan, Kun-Liang .
CELL, 2006, 126 (05) :955-968
[10]
Curcumin for chemoprevention of colon cancer [J].
Johnson, Jeremy James ;
Mukhtar, Hasan .
CANCER LETTERS, 2007, 255 (02) :170-181